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The gut microbiome is widely accepted to have a significant impact on human health
yet, despite years of research on this complex ecosystem, the contributions of different
forces driving microbial population structure remain to be fully elucidated. The viral
component of the human gut microbiome is dominated by bacteriophage, which are
known to play crucial roles in shaping microbial composition, driving bacterial diversity,
and facilitating horizontal gene transfer. Bacteriophage are also one of the most poorly
understood components of the human gut microbiome, with the vast majority of viral
sequences sharing little to no homology to reference databases. If we are to understand
the dynamics of bacteriophage populations, their interaction with the human microbiome
and ultimately their influence on human health, wewill depend heavily on sequence based
approaches and in silico tools. This is complicated by the fact that, as with any research
field in its infancy, methods of analyses vary and this can impede our ability to compare
the outputs of different studies. Here, we discuss the major findings to date regarding
the human virome and reflect on our current understanding of how gut bacteriophage
shape the microbiome. We consider whether or not the virome field is built on unstable
foundations and if so, how can we provide a solid basis for future experimentation. The
virome is a challenging yet crucial piece of the human microbiome puzzle. In order to
develop our understanding, we will discuss the need to underpin future studies with
robust research methods and suggest some solutions to existing challenges.
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INTRODUCTION
The human gastrointestinal tract (GIT) is a complex environment containing billions of
microorganisms (1). Changes in oxygen concentration, pH, nutrient availability, water availability
and bile salts shape the relative abundance of microorganisms from all domains of life (fungi,
protists, bacteria, and archaea) (2–5). Of these microorganisms, bacteria are by far the most
characterized, making up the vast majority of the DNA sequences and biomass (6, 7). This bacterial
community also plays a central role in normal physiology of the mammalian gut by facilitating
metabolic functions, protecting against pathogens and modulating the immune system (8–10).
Similarly, alterations in the composition and abundance of this bacterial community are closely
associated with diseases such as irritable bowel syndrome (IBS), inflammatory bowel disease
(IBD), colorectal cancer (CRC), Clostridium difficile infection (CDI), obesity, and neurological
disorders (11–15). However, the forces that shape the composition of these bacterial communities
remain poorly understood and this has slowed the development of microbiome based therapeutics
and biomarkers.
Bacteriophage (phage) are viruses that infect prokaryotic hosts and play crucial roles in
shaping the composition and diversity of bacterial communities in many environments, facilitating
horizontal gene transfer, and nutrient turnover through continuous cycles of predation and
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coevolution (16–18). To date, the majority of viral metagenome
(virome) research has been focused on environmental
communities such as those in the ocean (19, 20). In this
environment, the virome is central to the movement of dissolved
organic matter across trophic levels of the ocean food chain and
between the surface and the depths of the water column (16, 21).
A growing body of evidence also suggests the virome can shape
the functional capacity of host communities encoding functions
such as photosynthetic genes in the photic zones of the ocean
(22) and bacterial virulence factors in pathogenic bacteria (23).
Phage make up the vast majority of the viral component of
the gut microbiome (24). They are also believed to play a key
role in shaping the composition and function of the human gut
microbiome in both health and disease (25–27). However, despite
being highly abundant in the gut (>1010 g−1) (28, 29) and having
considerable impacts on microbial ecosystems, they remain one
of the least understood members of the gut microbiome. Early
sequencing studies of the human gut virome estimated that it was
dominated by novel sequences, with only 41% sharing homology
to databases (30). However, as sequencing platforms and library
preparation methods improved and yielded a more detailed view
of the virome, this unknown majority or “viral dark matter” was
found to make up an even greater proportion of the virome,
lowering the identifiable fraction to as little as (1–14%) (31).
Since phage were first identified by Frederick Twort in 1915
(32), culture-basedmethods such as plaque assays have been used
to screen and quantify phage titers from many environments.
Today, these methods still play a central role in identifying
phage which target specific bacteria and have contributed to
our understanding the mechanics of phage host interactions and
replication cycles. However, as the vast majority of phage-host
pairs in the gut are unknown, these methods are not suited to
large-scale characterization of a complex ecosystem such as the
human gut. Additionally, many of bacteria in the human gut are
not routinely cultivated, despite recent advances (33). As a result,
virome studies lean heavily on sequencing based metagenomic
approaches to investigate gut phage communities and to try
to understand their role in shaping the gut microbiome (31).
This involves sequencing the total viral DNA and RNA from
a community following physical separation from the bacterial
component, using assembly software to recreate the viral
genomes within that community and characterizing abundance
and function of those genomes. However, many sequence-based
virome studies exclude viral dark matter from analysis, working
largely with a small fraction of known phage sequences (usually
1–14% of the dataset). This can have profound implications
for the conclusions drawn from these studies, as changes in
the known fraction may not reflect changes in the virome as
a whole. As a result, database-independent analysis methods
are increasingly being used which include both known and
unknown fractions of the virome (29). However, high levels of
inter-individuality make biological signals across virome studies
difficult to detect (24, 34, 35). Furthermore, virome studies are
particularly susceptible to methodological bias due to difficulties
in benchmarking de novo bioinformatic tools and the dominance
of unknown sequences in virome datasets (36–38).
We will discuss phage of the human gut virome and their
interactions with the microbiome. We will also highlight how
little we know about their role in human health. Finally, we will
discuss critical areas of virome analysis methods which must be
addressed and improved upon if we are to fully understand the
role of phage in shaping the microbiome and human health.
HOW PHAGE INTERACT WITH BACTERIAL
HOSTS
Phage Infection Cycles
As obligate parasites of bacteria, phage persistence in a microbial
ecosystem is dependent on the presence of a suitable sensitive
host. Phage infection is typically followed by one of two
replication cycles, lytic or lysogenic (39) (Figure 1A). In both
cases a phage virion binds to the host cell surface using a phage
receptor-binding protein triggering the insertion of its genome
into the host. For lytic phage, subsequent translation of the
phage genetic material by the host cell results in the replication
of the phage genome, assembly of phage particles and lysis of
the host. This results in the release of new phage virions into
the environment that can infect nearby hosts. Alternatively,
lysogenic infection results in the replication of the phage genome
within the host cell without the immediate synthesis of phage
virions. The phage genome may integrate into that of the host
where it exists as a prophage, replicating together with the
host genome and thus persisting in resulting daughter cells.
In the case of pseudolysogeny, the phage genome persists as
an episome within the host cell, separate to the host genome.
In order to ensure subsequent daughter cells contain phage
genomes pseudolysogenic phage can use maintenance systems
such as toxin-antitoxin (40, 41). However, cases of daughter
cells lacking pseudolysogenic phage have also been reported (41).
Following an induction event, the lysogenic phage will initiate
the translation of its genome and subsequent production of
phage virions leading to host lysis. Additionally, phage such as
M13 undergo chronic non-lethal infection cycles, where newly
produced virions exit the cell without lysis (42). However, little
is known about the prevalence of these different lifecycles in the
human gut.
Resistance and Counter-Resistance
Bacterial hosts employ a wide array of phage resistance
mechanisms which have been comprehensively reviewed by
Labrie et al. (43) and Rostøl et al. (44). To prevent phage
adsorption, bacterial cells can differentially express or mutate
cell surface receptors (Figure 1B1) (45, 46), S-layer proteins
(47), or produce protective cell surface polysaccharides (48).
Additionally, bacterial hosts can reduce the numbers of phage
particles available to infect hosts by producing outer membrane
vesicles (49). These bind and sequester phage particles, reducing
their numbers in the environment and thereby the risk of
infection. Should the phage successfully bind to the appropriate
surface receptor, the fate of the host is not yet sealed as anti-
phage resistance mechanisms extend to all steps of the phage
infection cycle.
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FIGURE 1 | Overview of phage-host dynamics in the gut. (A) Phage infection can lead to virulent or temperate replication cycles. Integrated temperate phage use
internal and external signals from hosts to determine if or when to enter the lytic cycle. (B) Bacteria can possess a wide array of defense mechanisms which target
different steps of the phage replication cycle. Similarly, phage encode a wide array of counter-defense mechanisms which target host defenses and allow the phage to
remain infectious. (C) Physical separation of phage and host (e.g., in mucous or in lumen) means that dynamics change along the radial and longitudinal axes of the
gut. (D) Strain-level variation can result from resistance by mutation or by phase variation.
Hosts can prevent phage DNA injection entirely by
modifying inner-membrane proteins (Figure 1B2) (50),
identify and degrade injected phage DNA using restriction
modification systems (Figure 1B3) (51) and CRISPR-Cas
systems (Figure 1B4) (44), chemically block phage DNA
replication (52), or prevent virion assembly (Figure 1B5) (53).
Should these defense mechanisms fail to prevent phage
replication within the cell, the bacterial host can sacrifice itself
in order to protect its sister cells (54). These are referred to
as abortive infection systems and act by shutting down cellular
functions to prevent phage release (Figure 1B6).
Phage defense systems are regularly encoded on mobile
genetic elements that can facilitate the transfer of resistance
across the bacterial community. However, due to their metabolic
costs bacterial cells rarely encode more than one of these
systems (55). This gives rise to complex dynamics between hosts
with the metabolic burden of resistance and susceptible hosts
with fitness advantages. In addition, a cell carrying a prophage
can be made resistant to other phage in what is referred to
as superinfection exclusion (56). To further complicate these
relationships, antagonistic coevolution of phage-host pairs has
led to the development of phage counter-resistance mechanisms,
which allow phage to remain infectious in the face of a
resistant host population (57). Phage counter-resistance can
range from glycosidases to degrade host capsules (58) and reveal
binding sites, to directed mutagenesis or hypervariable receptor
binding proteins (59–61). These systems allow phage to retain
compatibility with modified host receptors and also allow for the
expansion of host range. Phage can even overcome host CRISPR-
Cas by mutating or deleting CRISPR target sites or expressing
anti-CRISPR proteins to directly interfere with CRISPR-Cas
activity (62). Some of the most striking phage counter-resistance
mechanisms include alteration of phage DNA to evade host
restriction modification mechanisms (63) and phage encoded
CRISPR-Cas systems that target and disable a range of host
defense systems (64).
Ecological Relevance of Phage-Host
Dynamics
Thesemechanisms of infection, resistance and counter-resistance
underpin virome-microbiome interactions. Thus, in order to
investigate how the virome shapes or reflects the microbiome,
we must first understand these interactions in the GIT.
Understanding phage-host interactions is also vital if we are
to use the virome as a diagnostic or therapeutic tool in
the future. To this end, numerous ecological models have
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been used to describe phage-host interactions in the context
of a biological system. Some models focus entirely on the
interplay of resistance and infectivity such as the arms race
dynamics model (65). This model proposes that phage infection
applies selective evolutionary pressure for mutations in the
hosts, resulting in resistant host populations. These mutations
in turn select for phage mutations that restore infectivity,
resulting in predator prey cycles (66). Other models take into
account phage-host density and the metabolic cost of resistance
such as the fluctuating-selection dynamics model (67, 68).
This proposes that as phage predation selects for resistant
hosts, it will also reduce the number of phage virions in
the environment. This absence allows for the expansion of
susceptible bacterial strains which lack the metabolic burden
of resistance and therefore out-compete resistant hosts in the
absence of phage. This transient resistance and infectivity
of phage-host communities results in short-term fluctuations
of phage and host numbers, but the long-term persistence
of both (69).
It is important to note that strain-level fluctuations of phage-
host are difficult to study in the context of the microbiome,
making it difficult to verify or quantify this model. Strain-level
variation within bacterial hosts cannot be detected by 16S rDNA
analysis (67) and hampers metagenomic assembly of phage (38,
70). Despite these challenges, recent insights have proposed that
variation in capsular polysaccharides encoded by the abundant
gut bacterium Bacteroides thetaiotaomicron play a central role in
phage susceptibility (71). This mechanism supports the concept
of fluctuating-selection dynamics, as phase variation of the
capsular polysaccharides creates heterogeneous host phenotypes
within an isogenic population. This in turn leads to transient
phage resistance across the population as host phenotypes are
dynamic and non-uniform (72). Additionally, this resistance can
occur without the need for horizontally-transferred resistance or
mutation (Figure 1D).
Phage replication not only requires the host to be present
and susceptible but it must also be metabolically active. It has
therefore been proposed that the metabolic state of the host is
one of the primary barriers to phage infection (69). In this way
bacterial hosts can be transiently resistant to phage infection due
to a lack of nutrient availability and a dormant growth phase,
without incurring the metabolic cost of encoding resistance
(Figure 1D) (73). Additionally, this mechanism would support
the proliferation of both phage and host in the GIT, independent
of resistance/counter-resistance dynamics. Nutrient availability
varies significantly along the GIT, which implies that phage-host
dynamics in the proximal or distal colon may be significantly
different to those in fecal samples (Figure 1C) (74, 75). As the
majority of virome studies draw conclusions from fecal samples,
our current understanding of phage host dynamics in the GIT
is limited.
The kill-the-winner ecological model is an extension of lotka-
volterra dynamics applied to phage-host interactions. This model
describes rapid changes of diversity and abundance of both phage
and their hosts. As the most abundant bacteria are killed by their
phages, other bacterial taxa will take over the ecological niche and
be subsequently killed by their phages. In this way high levels
of phage-host diversity and abundance are maintained (76). In
ecosystems where lotka-volterra or kill-the-winner dynamics can
be applied, phage exhibit an exclusively predatory relationship
on hosts and the microbial biomass is significantly below the
carrying capacity of the ecosystem (77, 78). However, in the
human gut ecosystemmicrobial biomass approaches the carrying
capacity of the ecosystem and the virus to microbe ratio (VMR)
is low (79). Despite reports of kill-the-winner dynamics in
infants (80, 81), this suggests that these models cannot not fully
explain phage-host interactions in the healthy adult gut (76).
Additionally, these dynamics overlook lysogeny and conditions
that govern the switch between lytic and lysogenic replication
cycles. Furthermore, it has been proposed that the gut virome
is dominated by temperate phage (82) and that compositional
changes in temperate phage communities are associated with
disease states (25). Consequently the mechanisms that determine
the switch between lytic and lysogenic replication cycles are also
central to understanding virome-microbiome dynamics. Recent
reports have described phage which can hijack bacterial quorum
sensing machinery to determine the density and metabolic
activity of the bacterial population from within the host cell
(83). This in turn, could dictate whether persisting within in the
host genome or excising and entering the lytic cycle would favor
phage proliferation (Figure 1A). In addition, single cell analysis
of phage-host interactions between the temperate P22 phage
and Salmonella typhimurium suggested that phage were directly
involved in creating transiently resistant host subpopulations
(41). This allowed for both lysogenic and lytic replication without
impeding host proliferation. Despite these intriguing insights,
little is known about the dynamics of temperate to lytic switching
in the mammalian GIT, highlighting a crucial target for future
virome research.
Ecological models that consider the switch between lytic
and lysogenic replication such as the piggyback-the-winner
model appear to support experimental evidence of phage-
host dynamics within the mammalian GIT (84, 85). This
model focuses on a lytic to lysogenic switch that is host
density dependent. Traditionally phage were believed to enter
the lysogenic cycle in cases of high VMR (i.e. increased
phage abundance, decreased host abundance) as a means to
persist in the environment until host density can support
lytic replication cycles. However, experimental evidence from
coral reef ecosystems suggested that phage also entered the
lysogenic cycle in high host density situations (84). Subsequently,
phage can “piggyback” on host success in the ecosystem at
that particular time. This model has also been proposed for
phage-host interactions on mucosal surfaces in the GIT. It
was suggested that at the mucosal surface, high bacterial
colonization and high VMR gives rise to piggyback the winner
dynamics, whereas deeper mucosal layers may give rise to
kill-the-winner dynamics due to the lower levels of bacterial
colonization and low VMR. This model is also supported by
reports that rapidly evolving Ig-like domains expressed on
phage capsids interact with mammalian host mucus glycans.
This in turn results in subdiffusive motion of phage within
mucus and allows them to persist in mucosal layers of the
gut (86, 87).
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While these models assist in our understanding of how the
virome interacts with the microbiome and the gut environment,
it is also important to consider their limitations. Phage-
host dynamics can be expected to change both radially and
longitudinally within the GIT (88) to reflect physical separation
of phages and hosts (Figure 1C) and metabolic changes in
the host populations (Figure 1D). They will also be heavily
influenced by dietary components and the composition of the
fecal matrix itself (5). To this end, sampling method and sample
compositionmust be considered when drawing conclusions from
virome data (Figure 2A). In the absence of studies of how these
dynamics change along the human GIT, phage-host interactions
must be interpreted as a snapshot of one particular point in space
and time.
COMPOSITION OF THE GUT VIROME
The gut virome consists of two elements, the temperate phage
located within bacterial genomes and the free virions or virus-
like particles (VLP). The VLP fraction is obtained by applying
several physical and enzymatic steps that remove dietary debris
and prokaryotic and eukaryotic genetic material (Figure 2B)
(29). As VLPs represent only a small fraction of the mass of
the microbiome, virome studies that do not carry out this viral
enrichment are limited primarily to the prophage sequences
within bacterial cells (89, 90). However, these prophage sequences
are in turn under-represented in studies that focus on the
VLP fraction. In order to understand the virome as a whole,
both elements need to be analyzed in tandem. The majority
virome studies focus on one of these elements in isolation
and as a result the apparent structure and composition of a
virome is heavily dependent on the physical preparation of
virome samples in the laboratory, the sequencing strategy, and
the bioinformatic methodology employed (Figure 2). This is
further complicated by the limited representation of human
gut viruses in databases and a reliance on phage taxonomic
classification systems which do not necessarily represent viral
biology. Consequently, our understanding of the taxonomic
composition of the phage populations in the human gut are
predictably varied and contradictory.
Taxonomic Composition
Sequence-based analysis suggests the identifiable fraction of
the gut virome is dominated by small single-stranded DNA
(ssDNA) phage of the Microviridae family and double-stranded
DNA (dsDNA) phage of the order Caudovirales (26, 29, 30,
FIGURE 2 | Impact of analysis choices on virome composition. Each step of a virome analysis protocol presents different options, each of which may affect the final
outcome. (A) Sample type. (B) Physical separation of VLPs. (C) Amplification of virome DNA can preferentially amplify certain viral taxa (see Figure 3). (D) Sequencing
chemistry, depth of sequencing and read length. (E) Assembly programs vary significantly in their ability to assemble virome data (see Figure 3). Reporting on the
composition of viral sequences with homology to reference databases excludes the unknown majority of the virome. Clustering viral sequences by gene composition
offers a promising alternative to database dependent methods by addressing high levels of sequence divergence in viral genomes.
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60, 91). However, bias in extraction methods has also been
reported to skew the abundance of Microviridae, calling into
question their dominance in the virome (discussed later) (92)
(Figure 2C). The Caudovirales are classified into three families
according to their distinctive virion morphology, consisting of
a head and a tail structure making them easily distinguishable
in microscopy studies. Siphoviridae exhibit long (sometimes up
to 1µm in length), non-contractile tails, Podoviridae exhibit
short non-contractile tails, whileMyoviridae exhibit a more rigid
contractile tail composed of distinctive sheath proteins. These
phage families have linear genomes, can encode a relatively
large gene repertoire (in extreme cases containing over 600
genes) and can exhibit both temperate and lytic replication
cycles. Early sequencing studies of the virome reported changes
in Caudovirales community composition being associated with
disease (25, 93, 94) and high Caudovirales abundance in EM
images (28, 95). However, reported abundance in EM images
could also be influenced by the fact that they are more easily
identified than other viral taxa. Possibly as a result of these
observations, Caudovirales composition and abundance has
become a regular focus of virome studies, where it is used as a
proxy for virome composition as a whole. However, as known
Caudovirales tend to represent a small minority of VLP sequences
in the human gut, caution should be taken when interpreting
these results.
Due to the current structure-based classification system of
Caudovirales, phage that exhibit significant functional similarities
can be considered members of different families due to
tail morphology. For example, phages P22 and lambda are
classified as Podoviridae and Siphoviridae respectively, despite
both undergoing the same replication cycle, sharing significant
similarity in gene sequences and exhibiting identical genome
organization (i.e., gene order and layout and regulation of
transcription). Additionally this classification system is not
grounded in sequence or protein sharing, yet sequence and
protein homology are the primary methods of identifying
Caudovirales in viromes (27, 34, 96, 97). This classification system
is therefore limited in its ability to reflect the biological role or
interactions of sequences classified as Caudovirales. A number of
recent studies have also highlighted anomalies in Caudovirales
taxonomy (98–100) and have proposed novel sequence-based
methods to restructure the viral order (99). However, these are
not without their own challenges, as shared genes and gene
cassettes have been found to blur the boundaries between various
dsDNA viruses (101, 102), which will be discussed in detail later.
Case Study of the Most Dominant Gut
Phage, CrAss
A prime example of the limitations of focusing on identifiable
Caudovirales alone when carrying out virome analysis is that of
crAssphage, one of the most abundant and successful biological
entities of the mammalian gut. First reported in 2014 using
novel assembly methods (103, 104), crAss was found to be six
times more abundant in publically available gut metagenome
samples than all other phage together. It made up to 90%
of VLP sequencing reads and 30% of whole metagenomes in
certain individuals, yet did not share homology with known
reference databases (104). As a result, crAss would have gone
entirely unnoticed using database-dependent analysis alone.
CrAss has since been found to be globally distributed, with
strains reflecting geographic distribution of human populations
(105). Intriguingly, the presence of distant relatives to crAss in
primates may suggest that crAss has coevolved with humans for
millions of years from ancestors shared with primates, to modern
Homo sapiens (105). These results highlight the importance of
the unknown majority of the virome in human health and why it
is critical to analyze the virome as a whole. Given the proposed
ubiquity and dominance of crAss in the human gut it is also
possible that the abundance of Caudovirales reported by EM
studies may in fact reflect members of the extended crass-like
phage family, which at the time were unknown.
The characterization of crAss and studying its role in the
gut microbiome has been hampered by a lack of database
representation, unknown host range and until recently (106),
unsuccessful attempts to form plaques on agar overlays. However,
its progression from an unknown abundant phage sequence to
a characterized dominant member of the gut virome provides
a useful framework in building our understanding of viral
dark matter. Its initial discovery was built upon by using
sensitive protein homology searches to identify an extended
family of crAss-like phage from human gut virome samples
(107, 108). Although sequence similarity across family members
was low, protein family-based clustering identified conserved
capsid proteins and predicted crAss to encode a short tail
similar to that of the Podoviridae family of Caudovirales (108).
Subsequently, crAss has also been identified in patients with
diarrhea and in Malawian infants (107). Additionally it was
found to be shared across healthy individuals and was capable
of stable engraftment in FMT treatments (109). However, the
host range andmechanism behind crAss ubiquity and abundance
remained unknown.
Through the use of enrichment-based techniques the host
for one member of the crAss family was confirmed to be
Bacteroides intestinalis, a finding previously suggested by co-
abundance profiling (104, 106). This provided new opportunities
to study the phage-host interactions of the most abundant phage
family in the human gut and its role in the microbiome. The
ability to culture crAss in vitro also led to the description of
one of the most intriguing aspects of this phage, its ability to
coexist with its host at high abundance. This has a profound
impact on our understanding of how the virome shapes the
microbiome, as it appears that in crAss-rich individuals the
dominant phage populations do not restrict the growth and
proliferation of their host. Furthermore, it is believed that crAss
persistence and coexistence with its host is not due to crAss
undergoing temperate replication, as it does not possess any of
the genes typically associated with lysogeny (106). Additionally,
crAss prophage sequences have never been observed in the
numerous Bacteroidales genomes available in sequence databases.
It is possible that crAss replicates in a pseudolysogenic manner,
existing as an episome within the host cell (41), that it facilitates a
chronic infection without killing the host cell (42), or that it can
exist in an extracellular carrier state (110). The high proportion
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of resistant host cells in culture (1–2%) could also suggest that
a host cell carrying crAss in a pseudolysogenic state could
confer resistance from infection as in superinfection exclusion.
However, experimental evidence suggests crAss replicates in a
lytic manner and its abundance in the gut is maintained by
transiently resistant hosts. As phase variant CPS and transient
resistance have been found to be central in phage-host dynamics
in other Bacteroides species (71), it is possible that these
mechanisms are also central to the unusual phage-host dynamics
observed in crAss both in vitro and in vivo. This theory is
supported by the reversion over time of some resistant clones
to sensitive states (106). Given the abundance of Bacteroides
and crAss in the human gut, phenotypic heterogeneity across
a host populations may be the central mechanism to support
stable interactions between some lytic phage and their hosts in
the microbiome.
Another possible explanation for sustained crAss-host
proliferation is the recently proposed “Royal Family” ecological
model (111). This suggests continuous kill-the-winner dynamics
occur at a strain-level rather than at a species or genus-level.
In this way, the abundance of both phage and host would
appear to be stable as fluctuations would occur below the level of
detection. Subsequently, detailed analysis of strain-level variation
between crAss and B. intestinalis could provide insights into the
importance of this model in the GIT. A similar study carried out
by De Sordi et al. (112) supports the “royal family model” and
gave intriguing insights into its mechanics. This study described
a point mutation in the tail fiber gene of P10 which is associated
with strain-level host expansion from Escherichia coli LF82 to
E. coli MG1655. Interestingly, this strain-level host switching
was only observed when phage and both hosts coevolved within
the murine model and was not observed when the two strains
were cultured separately. Subsequent experiments revealed that
switching required the presence of an intermediate host E. coli
MEc1. These observations suggest that crAss-host stability in the
gut could be caused by a wide array of strain-level and phenotypic
variation. However, as strain-level variation is difficult to observe
in vivo and in vitro, novel analytical approaches may needed to
reveal crAss phage-host dynamics in the GIT.
The proliferation of both phage and host as is seen in crAss-
B. intestinalis dynamics could also suggest that the presence
of phage could confer an ecological advantage to the host.
This phenomenon has been regularly reported in the ocean,
where phage infecting cyanobacteria were found to carry
auxiliary metabolic genes encoding photosynthetic genes (22,
113). Similarly, phage-mediated transformation of the host has
also been well-established in disease such as the lysogenic phage
encoding shiga toxin (23) and cholera toxin (114). It is therefore
highly likely that in the dense and diverse ecosystem of the
gut, extensive horizontal transfer of genes between hosts is
facilitated by phage infection. In this way the virome may play a
crucial role in shaping the functional capacity of the microbiome.
One report of the presence of significant numbers of antibiotic
resistance genes in gut virome sequences (115) was later shown
to have probably resulted from bacterial contamination and
confirmed that examples of phage-encoded antibiotic resistance
genes were rare (116). This could be due to the efficiency of
phage replication and the fitness cost of carrying antibiotic
resistance genes. Without the selective pressure of antibiotics,
viruses that pay the metabolic cost of carrying antibiotic
resistance genes could be outcompeted (116). Additionally, the
selective evolutionary pressure of remaining infectious in the
face of a constantly adapting host may outweigh the need to
preserve the host from an antibiotic. The follow up study also
highlighted the importance of using stringent alignment criteria
and validating results when classifying sequences or proteins.
Due to the extensive unknown fraction of the virome and the
difficulty in benchmarking classification criteria, lenient cut-offs
can often lead to false conclusions of virome composition and
function (116–118).
It is tempting to propose that the piggyback-the-winner
hypothesis could be extended by considering the possible
fitness advantages of carrying a prophage over and above
superinfection exclusion. Such advantages could include carrying
a virulence factor or providing access to a novel nutrient
source (119, 120). Prophage-encoded fitness advantages have
been observed in a number of pathogenic bacteria. These include
prophage-encoded toxins (23, 114), alteration of O antigens in
Salmonella and Shigella (121, 122) and phage-encoded glycosyl
transferase operons which drive Salmonella LPS diversity (123).
Furthermore, the horizontal transfer of virulence factors through
temperate phage was found to be increased in gut inflammation
(124). Additionally, recent observations in Staphylococcus aureus
prophage (125) have described the packaging of chromosomal
host DNA in phage capsids through a mechanism deemed lateral
transduction. This mechanism suggests that phage-mediated
horizontal gene transfer occurs at much higher rates than
previously thought and that it plays a role in disease. However,
the extent to which lateral transduction mediates gene transfer
in the gut microbiome remains unknown. Examining phage-
encoded auxiliary metabolic genes and how they shape the
functional capacity of the gut microbiome is hindered at a large-
scale metagenomic level by the complexity of fecal samples
themselves. Dietary components and the sheer abundance and
diversity of bacterial cells in feces make it difficult to completely
remove bacterial sequences from virome samples. Use of density
gradients such as CsCl are reasonably effective at generating viral
particles devoid of cellular contamination, but will introduce
bias in favor of particular viral capsid types (126) and are not
suited to large-scale projects due to their associated manual
workload. As a result, background contamination exists in the
vast majority of virome samples (29, 116, 117) making it difficult
to determine if a gene is of viral or bacterial origin. This may
be further complicated by potential gene transfer agents (GTAs)
(127) in gut VLP samples. GTAs are defective phage virions that
exclusively carry fragments of bacterial chromosomal DNA and
are used by bacteria as a means of HGT. As a result sequences
within GTAs are difficult to differentiate from background
contamination. However, the presence and prevalence of GTAs
in human gut microbiome remains to be seen. Overall, despite
the evidence of phage shaping the functional capacity of host
communities, it is challenging to determine the extent to
which phage transfer genes relevant to human health within
the microbiome.
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Controversy Surrounding the Core Virome
The widespread geographical distribution and stability of crAss-
like phage supports the concept of a core human virome, which
was initially proposed by Manrique et al. (26). This was in
response to a growing body of evidence that a core microbiome
played an important role in human health. The study proposed a
core of 23 viral sequences, one of which being the original crAss
genome, which were shared across more than 50% of samples
from an independent cohort of 62 healthy individuals. However,
these findings were in stark contrast to the well-established belief
that the human gut virome is highly individual-specific at a
sequence level (29, 34, 35, 128). This disparity is largely due to the
criteria used to define the presence of a viral sequence in a sample.
If a single sequencing read from an individual could align to a
particular viral assembly, the assembly was deemed to be present.
This lenient criteria does not account for the modular nature and
extensive gene sharing that occurs across dsDNA viral genomes
(99, 101, 129). Thus, it would not be possible to differentiate the
true presence of a viral sequence in a sample from the presence
of a shared gene between two unrelated phage. This in turn,
would lead to an inflated number of viral sequences being shared
across individuals. However, the concept of a core virome has
received support from a recent study with adult monozygotic
twins, in which 18 contigs were found to be present in all
individuals (n = 42) (34). Here, more stringent read recruitment
criteria were applied to differentiate shared genes from the true
presence of a viral sequence in a sample. Interestingly more
than half of the viral assemblies identified across all individuals
were homologous to crAss. It should be noted however, that
these assemblies may also represent fragments of the same phage
genome or family.
In contrast to these findings and to the proposed global
distribution of crAss phage in human populations, the
compilation of a large-scale gut virome database called into
question the existence of a core human gut virome at a
sequence level (24). By examining VLP metagenomes from
572 individuals, this study proposed that a core human gut
virome does not exist. Recently, Shkoporov et al. (128) too
made observations which support these findings by examining
the virome of 10 individuals across a 12-month period. Here,
a personal persistent virome (PPV) was observed that was
composed of viral sequences detected in at least six of the 12
monthly time points. In accordance with previous longitudinal
studies (60, 82), some viral sequences were present at nearly all
time points within an individual. However, the virome was also
highly individual-specific and viral sequences were not shared
across the PPV of all individuals which supports the findings
of Gregory et al. (24). This high level of inter-individuality in
the gut virome hampers our understanding of the virome in
disease as it is difficult to detect common viral signals within
or between cohorts. While it is likely that the individuality of
the virome is driven by infection and resistance dynamics, the
level of taxonomic resolution at which the virome is studied
is also a contributory factor (35). Sequence-based virome
studies are carried out at the level of metagenomic assembly
due to the absence of universal marker genes, limited database
representation and established taxonomic organization. This
represents species or strain-level resolution and is in contrast to
the majority of bacterial metagenomics studies, which tend to be
analyzed at higher taxonomic ranks such as genus or family. It
is possible to find patterns across virome cohorts using a minor
subset of known viral sequences and by excluding unknown
sequences (25, 27, 130, 131). However, it is not known if these
subsets represent the dynamics of the virome as a whole. To this
end, a number of clustering programs have been developed that
group viral sequences based on shared protein families (99, 129)
such as vConTACT (99). This is a similar approach to that which
was used to establish the extended crAss family despite low levels
of nucleotide similarity between family members (107, 108).
In this way, protein-based clustering of the virome can reveal
compositional patterns across individuals that were not visible
at a nucleotide level. Furthermore, this approach allows for
both the known and unknown components of the virome to be
included in analysis giving new perspectives to the virome in
health and disease.
By applying this protein family clustering approach (102)
to the same longitudinal cohort Shkoporov et al. (128) gained
new insights into the existence and composition of a core gut
virome across individuals. This phylogenetic core was composed
primarily of crAss and Microviridae and was not identifiable
at a nucleotide level. Intriguingly, this core was not composed
of temperate phage which is in contrast to observations in
previous reports (82). Furthermore, temperate phage were found
to make up a minor subset of the core virome both within and
between individuals. These findings suggest that mechanisms
other than lysogenic replication are responsible for long term
stability of the virome within healthy individuals. Moreover, they
are in accordance with the global distribution and persistence
of crAss in the human gut and ecological models such as the
“royal family model.” Upon clustering the stable fraction of
individual viromes (PPV) the largest and most interconnected
viral cluster as associated with known Caudovirales sequences.
This is in accordance with previous observations (99, 129) and
reflects extensive shared genetic content across this order. It is
also likely that this extensive gene sharing influenced previous
database-dependent reports of temperate phage andCaudovirales
dominance in the human gut virome. Furthermore, it highlights
the importance of considering shared genes and gene cassettes
when setting alignment criteria.
GUT VIROME IN DISEASE
Given the extensive evidence that phage can shape the
composition and function of bacterial communities, the virome
of the human gut has been studied in a number of diseases.
However, as with the concept of the core virome, findings
have been somewhat contradictory and any potential role for
the virome in shaping the microbiome in disease remains
elusive. Studies have reported gut phage populations were not
significantly altered in diseases such as colorectal cancer and
HIV-associated AIDS (130, 132), despite established associations
between the gut microbiome and these diseases (15, 133). This
contradicts the established view that the gut virome and gut
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microbiome are closely linked and is more likely to reflect
limitations of different analysis methods. These limitations
include lenient alignment criteria to reference databases and
the exclusion of viral dark matter from analysis. Furthermore,
reports of changes in phage populations associated with
diseases are often limited to changes in the composition of
known Caudovirales (25, 90, 97, 131). Given the limitations
of Caudovirales taxonomy and the challenges presented by
extensive gene sharing across the order, these findings provide
little insight into any role of the virome in disease.
An intervention study by Gogokhia et al. (134) sought to
target cancer associated bacteria adherent invasive E. coli and
Fusobacterium nucleatum with lytic phage in a germ-free mouse
model. However, a direct interaction between the mammalian
immune system and phage virions resulted in an exacerbated
colitic reaction. The authors also proposed that phage DNA
plays a central role in phage interaction with the mammalian
immune system as empty phage capsids did not induce an
immune response. Similarly an in vitro study using S. aureus
and Pseudomonas aeruginosa phage observed a production
of both pro and anti-inflammatory cytokines from peripheral
blood mononuclear cells following endocytosis of purified phage
virions (135). These observations are supported by the proposed
ability of phage virions to cross the mammalian epithelial barrier
in vitro via peptide sequences expressed on the capsid surface
(136, 137). In this way it is possible that phage communities
in the human gut shape the gut microbiome indirectly through
interactions with the mammalian immune system. This concept
of phage translocation and interaction with mammalian immune
system has also been discussed in a number of reviews and
perspective pieces as follows (138–141). Through the induction
of a pro or anti-inflammatory response, phage could facilitate
conditions that would favor a particular host or replication
cycle. It is also possible that proposed phage–immune system
interactions are driven by bacterial populations to facilitate
infection or persistence in the human body. This was first
demonstrated by lysogenic Pf phage which triggered maladaptive
viral pattern recognition receptors and facilitated the chronic
infection of Pseudomonas aeruginosa in murine and human cells
(142). This was also the first reported case of a directly pathogenic
effect of phage in bacterial infection and demonstrated that phage
do not need to directly encode virulence factors to impact the
virulence of their host.
Fecal Microbiota Transplantation
FMT (fecal microbiota transplantation) is an emerging and
experimental therapy that aims to restore healthy gut function
through infusion of a fecal slurry from a healthy individual
to the colon, cecum, or duodenum of the recipient. It has
been shown to be very effective in the treatment of recurrent
CDI with donor bacteria colonizing recipients for up to a
year (143) and reported success rates of 80–90% (144). The
first evidence that the virome had potential as a tool to shape
the microbiome and may play a role in the efficacy of FMT
treatment was reported by Ott et al. (145). In this study,
patients with relapsing CDI received fecal filtrates from healthy
donors that resulted in CDI symptoms being eliminated for
up to 6 months. Furthermore, recipient phage populations
were substantially altered, resembling those of the donor for
a minimum of 6 weeks. Surprisingly, Lactococcus phage were
reported to dominate both donor and recipient virome, despite
Lactococcus spp. representing only a minor fraction of the
gut microbiome. This could reflect a dominance of lactococcal
phage in the donor and recipient, implying lactococcal phage
play an important role in homeostasis in CDI. However, phage
sequence databases are dominated by those which are industrially
relevant and cultivable, which includes lactococcal phage (146).
As a result, unknown sequences are statistically more likely to
align to lactococcal phage and other cultivable or industrially
relevant sequences when lenient alignment criteria are used.
Thus, the dominance of lactococcal phage in the virome of
FFT recipients is likely to be yet another artifact of database-
dependent analysis methods. It should also be noted that, in
accordance with the majority of database dependent virome
studies, lactococcal phage aremembers of the orderCaudovirales.
This supports the concept that Caudovirales dominance reported
at an order and family level in the gut virome could be driven by
gene modules shared with Caudovirales in reference databases.
However, the resemblance of the donor virome to that of the
recipient suggests that, regardless of classification limitations, the
virome plays a significant role in the maintenance of homeostasis
in the gut. A subsequent study by Draper et al. (109) also
reported the stable engraftment of donor phage populations in
recipients for up to 12 months. In accordance with observations
at a bacterial level (143, 147) successful phage engraftment
was also dependent on specific donor-recipient pairings. It
should be noted that the role of other elements present in
the filtrate (i.e., chromosomal DNA, plasmids, bacterial cellular
components, and signaling molecules) remains unknown and
could also play a role in the restoration of healthy gut function
in CDI. With conditions such as ulcerative colitis (UC) that
are characterized by more subtle microbiome changes than
CDI, successful FMT treatment (i.e., remission and mucosal
healing) was not associated with changes in the phage population
(148). This is in contrast to reports of alterations in bacterial
diversity following FMT in UC (149). Additionally, changes in
the diversity of phage populations between healthy and UC
cohorts were not observed (148). These observations were in
contrast with previous IBD virome studies, which reported
differences in phage alpha diversity between healthy and UC
cohorts (25, 97).
Inflammatory Bowel Disease
Inflammatory bowel disease is a prevalent chronic disorder of
the gastrointestinal tract with both genetic and environmental
risk factors (150). The composition of gut bacteria and their
interaction with the host immune system are believed to be
central to its pathology, yet the etiology of the disease remains
poorly understood. Given the evidence that the virome can
interact directly with the host immune system and shape the
composition and function of the microbiome, both fecal and
mucosal phage communities have been studied in IBD. Current
understanding of phage populations in IBD has focused on
VLPs, proposing that disease-specific patterns of Caudovirales
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are linked to Crohn’s disease (CD) and ulcerative colitis (UC).
Furthermore, these changes in VLP composition have been
reported not to reflect alterations of the bacterial community.
However, the details of these compositional changes vary between
studies (25, 27, 93–95, 151).
Early IBD virome studies using the Roche 454 sequencing
platform were limited by sequencing depth. These studies
observed lower diversity and greater variation in the fecal VLP
communities of patients with CD relative to healthy samples
(93). The same group performed another sequence based analysis
of the fecal and mucosal VLP community of CD and observed
greater viral load and diversity in the feces than mucosa
of all individuals (151). Additionally, virome alpha diversity
was reported to be significantly lower in disease. However,
in contrast to their previous study, it was also reported that
both healthy and CD cohorts were dominated by Microviridae
rather than Caudovirales. Another study that analyzed the first
mucosal virome in pediatric CD (94) proposed a dominance of
Caudovirales phage overall and detected a single viral sequence
in colonic mucosal samples from patients with CD. While this
may suggest an extreme dominance of this virus in the mucosa
of pediatric CD it more likely reflects insufficient sequencing
depth resulting from low biomass samples and should be treated
with caution.
As sequencing technology progressed, researchers were
granted more detailed insights into the virome in IBD. However,
these insights contradicted previous findings and highlight the
impact of sequencing platform on results. This could also suggest
that our understanding of the virome in disease will continue
to change as sequencing technology progresses. Illumina-based
studies reported disease-specific increases in Caudovirales alpha
diversity in the VLP viromes of UC and CD compared to
healthy controls in adults (25) and children (97). Intriguingly,
these alterations were also reported not to reflect changes in the
bacterial community (bacteriome). Conversely, decreased alpha
diversity was observed in Caudovirales families from the mucosal
VLP virome of UC relative to healthy controls (27). This supports
the idea that viral communities and ecological models differ at
different spatial locations within the gut. Additionally, it suggests
that phage of the order Caudovirales play a central role shaping
the microbiome in IBD. However, as with other studies of the
virome in disease, these findings are limited to minor identifiable
fractions of the dataset and offer little by way of insight into the
role of phage in IBD.
In an effort to expand our understanding of the gut
virome in IBD and move beyond the limitations of viral
sequence databases, Clooney et al. applied the whole-virome
analysis (WVA) (35) protocol discussed earlier to the keystone
IBD virome dataset published by Norman et al. (25, 35).
In this way, it was possible to gain novel insights into the
composition viral dark matter in this disease. Contrary to
the original findings of the study, alterations in the whole
virome mirrored those of the bacteriome, and differences in
overall virome alpha diversity were not seen across the whole-
virome. In accordance with current understanding the gut
virome, high levels of inter-individuality were observed, and
were likely to conceal any patterns in virome composition across
individuals. Subsequently, we followed the protocol established
in Shkoporov et al. (128) to cluster viral sequences according
to gene content. This revealed a core of primarily lytic phage
in healthy individuals and supported observations of Shkoporov
et al. (128). However, this healthy core was also found to
be absent in patients with IBD where it appeared to be
replaced by a community of temperate phage. The majority
(six) of the eight viral clusters which made up the healthy
core virome in this analysis did not share homology to known
viral sequences further highlighting the biological signals that
may be missed when relying on database-dependent methods.
Interestingly, one of these healthy core virome clusters was
identified as crAss. This supports previous observations of its
ubiquity in healthy human populations, low rates of detection
in unhealthy individuals and its role in the core healthy
human virome.
One possibility is that in the inflamed gut, environmental
stresses from the human immune response such as antibodies
and reactive oxygen species, leads to increased induction of the
prophage present in the bacterial microbiome. The physiology of
bacterial cells and the composition of the bacterial community
influences whether integrated prophage enter the lytic or
lysogenic replication cycle (Figure 1A) (83, 152). It is therefore
likely that temperate virome would react to environmental
stress and resulting changes in the host community. This
increased lytic replication and subsequent death of bacterial
hosts would correspond with the observed reduction in bacterial
alpha diversity associated with IBD. It would also correspond
with the observed increase in in free phage virions (95) and
temperate VLPs in disease (35). Additionally, the resulting
increase of bacterial cell wall components and debris available
to interact with the human immune system could perpetuate an
inflammatory response. In accordance with in vitro reports, it
is also possible that increased cell wall permeability associated
with inflammation allows for increased phage translocation
(137) and interaction with the host immune system (134,
135, 153). The observations of Clooney et al. (35) provide
a novel theoretical, mechanistic rationale for the interaction
of the whole virome and the microbiome in disease, beyond
taxonomic assignment and compositional patterns of the known
minority. Additionally, they provide comprehensive evidence to
support the mechanisms that had been previously proposed by
Norman et al. (25).
The extent to which the switch from temperate to lytic
replication cycles and the composition of the core virome shape
the gut microbiome and influence human health and disease
remains speculative. However, the analysis approach outlined
by Clooney et al. (35) paves the way to a better understanding
of how the interplay between the microbiome and the virome
reflects or influences human health and disease. By allowing
the detection of biological signals across the entire virome it
is now possible to identify viral signals associated with disease
which had been previously undetected. The WVA approach
is also supported by the methods used to characterize the
crAss-like family (106–108). CrAss has progressed from an
unknown viral sequencing anomaly to providing insights into the
composition and function of the healthy human gut virome. In
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turn, the methods used in this progression provide a framework
to characterize unknown but biologically relevant sequences
identified by WVA.
It should be noted, that although many virome studies tend to
report the dominance and composition of known Caudovirales,
this provides little insight into the biological impact of these
phages or how they shape the gut ecosystem. Caudovirales
dominate reference databases, exhibit extensive gene sharing
across families and orders and feature temperate phage genera
(101, 102, 154). It is therefore likely that database-dependent
methods of virome analysis classify unknown dsDNA virus
sequences as known Caudovirales due to shared genes or gene
cassettes and lenient detection criteria. As the representation
of gut virome sequences in databases improves with efforts
such as those carried out by Gregory et al. (24) and the
characterization of crAssphage (106, 107), database-dependent
analysis methods may be able to better reflect the composition
and dynamics of the virome. However, as extensive gene sharing
remains a central part of dsDNA viral genomes it is essential
that stringent alignment criteria are used to differentiate shared
functional modules from the presence of a particular virus (36,
155), regardless of the database used. Additionally, it is crucial
that these alignment methods and their findings are validated
to avoid misleading conclusions as to virome composition or
function (116–118, 145).
ADDRESSING THE CURRENT
CHALLENGES OF VIROME RESEARCH
As has been discussed, studying phage of the human gut
microbiome is made challenging by the composition of the
sample (usually a fecal specimen; Figure 2A). In order to enrich
for the VLP fraction of the virome, extensive mechanical,
chemical, and enzymatic processing is required to remove
cellular DNA and dietary components (Figure 2B) (29, 126).
Unfortunately, this results in particularly low DNA yields that
can complicate the generation of sequencing libraries. This
challenge is more pronounced in mucosal virome studies where
DNA yields are lower again (132, 156). As a result, all but
one (26) virome study to date have depended on multiple
displacement amplification (MDA) of viral DNA to reach
sufficient quantities to sequence. As with all metagenomics, it
is crucial to find the balance between sequencing chemistry,
depth of sequencing and read length. These factors have
profound impacts on the final virome sequences available for
downstream analysis. This was highlighted by the differences
in virome alpha diversity reported by 454 pyrosequencing,
when compared to deeper sequencing on the Illumina platform
as previously discussed. Short read platforms such as the
Illumina HiSeq are a means to perform deep sequencing of
the virome with low error rates and relatively low input
DNA requirements. However, these libraries can also lead to
fragmented assemblies and poor recovery of viral genomes
(38). Long read sequencing offers a promising solution to
this assembly challenge, as it is possible to sequence entire
viral genomes on a single read (Supplementary Table 1). This
overcomes hypervariable sequences and repeat regions in viral
genomes which hamper assembly (61). Currently long read
sequencing platforms also require very large quantities of
unfragmented DNA, which can be challenging acquire from
virome samples. As a result, the initial DNA yield and the
amplification step directly influence the sequencing chemistry,
read depth and read length which can be used with virome
sequences (Figure 2D). The MDA step has also been reported
to introduce considerable bias into the composition of the
resulting virome which must be considered when drawing
conclusions from data (Figure 3A) (157, 158). Studies have also
reported MDA preferentially amplifies small circular ssDNA
viruses, which include the family Microviridae (Figure 2C) (92).
This could call into question both the reported abundance
and ubiquity of this family across individuals. Although it is
difficult to quantify the extent to which preferential amplification
occurs, recent meta-analysis of gut virome studies suggested
Microviridaemay be 10-fold lower in abundance than previously
thought (24). It is believed that priming biases of the random
hexamers used in the MDA reaction do not prime equally
across all genomes, making quantitative interpretation of virome
data difficult.
MDA bias can also have a significant impact on qualitative
analysis of the gut virome. As the concentration of the DNA
template also impacts the products of an MDA reaction, initial
log-fold differences in the abundance of viral sequences are
exaggerated by MDA (159, 160). This results in extremes of
both high and low read coverage and uneven representation
of the initial metagenome. As high-abundance sequences
sequester sequencing resources, low-abundance sequences can
be insufficiently covered (161). These coverage extremes have
profound impacts on a number of steps in bioinformatic
pipelines, but in particular metagenomic assembly (38, 161).
A recent comparison of all assemblers used in virome
studies to date observed that both high and low-coverage
sequences resulted in fragmented assemblies and recovered
only small proportions of viral genomes (38). Furthermore,
samples were spiked with an abundant (107 plaque-forming
units ml−1) exogenous lactococcal phage Q33. These samples
underwent identical extraction amplification and sequencing
and resulting viromes were then assembled using all assembly
methods which had been reported in virome studies at the
time (16). Ten of the assemblers either failed to recover
or significantly fragmented the Q33 genome and only one
assembler recovered the genome at the correct length (Figure 3B)
(38). These results suggest that numerous and potentially
biologically relevant viral sequences may be not only be
skewed in abundance but also excluded by current virome
analysis protocols. This also means that we see the virome
through the lens of the extraction protocol before any decision
has been made to use database-dependent or independent
methods (Figure 2, Supplementary Table 1).
As with many microbiome studies, conclusions from
virome studies are primarily drawn from relative rather than
absolute abundances of sequences. As has been discussed,
these abundances are often skewed by MDA bias. This
ambiguity highlights the need for quantitative analysis protocols
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FIGURE 3 | Examples of how virome composition is influenced by key steps in analysis. (A) Three samples were subjected to identical filtration and DNA extraction
steps. One set was amplified and prepared for sequencing using the Illumina TruSeq library kit while another set of unamplified samples were prepared using the Accel
1S Plus kit. Both sets were sequenced on the Illumina HiSeq platform. Differently treated samples differ in terms of final composition, represented in bar plots. Each
color represents the relative abundance of a unique viral contig in each sample. Abundance does not reach 100% in the unamplified sample as the higher level of
richness also hampered assembly [adapted from (128)]. (B) Impact of assembly software on final virome composition. A fecal samples was spiked with ϕQ33 107 PFU
ml−1, extracted and sequenced. These sequences were assembled using 16 assembly programs. Only one assembler identified the genome in a single contig of the
correct length. Five assemblers completely failed to assemble the genome and a further five generated fragmented assemblies (38).
in virome studies as was recently described (29, 35, 128).
These studies reported significant differences in the overall
viral load between individuals. This total viral load was
also correlated negatively with viral alpha diversity within
the sample and the presence of abundant and typically
virulent phage such as Microviridae and crAss. These results
suggest that high viral load is associated with a low number
of abundant phage, which consequently mask underlying
temperate phage diversity. This also suggests the maintenance
of high-abundance non-temperate phage may be closely linked
to the health status of the gut. Subsequently, this may act
as a useful biomarker for disease and provide insight into




Sequence-based analysis of the bacteriophage in the human
gut has revolutionized our view of the gut virome and its
relationship with the microbiome. However, this new insight
has also revealed how little we know about this relationship.
Our current understanding is founded predominantly on
extending knowledge generated in reductionist phage-host
studies in vitro, or by large scale metagenomic studies of
the VLP fraction. While these in vitro studies give detailed
insights into themechanics of individual phage-host interactions,
the prevalence of these interactions in the gut ecosystem
remains speculative. Additionally, numerous studies have also
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reported that these interactions can change dramatically in the
gut (112, 134). Large-scale metagenomic studies suggest that
the virome and the microbiome are closely linked, but these
studies tend to give broad overviews of subsets of the virome
and lack details on the phage-host interactions. This leads
to significant gaps in our understanding of how phage-host
dynamics in vitro differ from phage-host dynamics occurring in
the gut.
Application of similar analysis methods across studies (i.e.,
MDA, alignment to reference databases, reports on Caudovirales
alpha diversity) allows for comparison across samples and
studies. However, many virome studies present inconclusive
or contradictory results that hinder the progression of the
field. Arguably the overreliance on these analysis methods is
largely to blame for the gaps in our understanding of the
virome. This is also supported by recent observations that
methodology had greater impact on the conclusions drawn
from virome studies than health or disease status (24). As
conclusions are drawn from minor fractions of data and as
detection criteria do not take into account phage biology
and evolutionary history, we must pose the question: is
the gut virome field built on unstable foundations? With
this in mind, due caution must be used when interpreting
the findings of virome data. As virome data is particularly
sensitive to methodological bias, conclusions must be considered
in the context of the analysis methods used (Figure 2,
Supplemetary Table 1). These limitations highlight the need for
radically new approaches to studying the virome if we are
to understand its role in shaping the microbiome in health
and disease.
Developments in sequencing library kits such as the Swift
Biosciences Accel 1S Plus kit or extraction protocols like
the linker amplified displacement LADs (36), offer potential
solutions to creating unbiased sequencing libraries from low-
input DNA yields. Through the removal of MDA bias and
spiking known concentrations of exogenous phage (29), it may
be possible to gain new insights into the true composition
and absolute abundance of the virome. As has been discussed
at length, the sensitivity of virome data to methodological
bias highlights the critical need for extensive optimization
and validation of all steps of virome analysis protocols, from
wet-lab extraction protocols (29, 36, 155) to bioinformatic
pipelines (37, 38, 161, 162). However, standardization and
consistency must not be at the cost of developing new methods.
Furthermore, when characterizing viral sequences it is crucial
to use stringent detection criteria to minimize the impact of
spurious alignments and the influence of gene sharing across
dsDNA viruses.
Significant progress has been made in increasing the
representation of gut phage in reference databases and there is a
growing consensus that viral taxonomy will soon move toward
sequence-based taxonomy (24, 163–166). However, proposed
protocols to add metagenomic sequences to current taxonomic
systems have not yet been accepted (167). Given the dominance
of unknown sequences in virome data it is therefore crucial
to accept the current limitations of phage taxonomy. Rather
than force the virome to fit current taxonomic systems, we
propose that future studies should allow the virome to reveal its
own targets for downstream characterization. Subsequently, we
have highlighted a method to analyze the virome in its entirety
using the WVA protocol. Furthermore, we have described a
framework to characterize unknown but biologically relevant
viral sequences that may be identified using WVA. In this way
it may be possible to address the gaps in our understanding of
phage-host dynamics in the human gut, and see existing datasets
in a new light.
To what extent the phage of the human gut shape the
microbiome will dictate whether it will be possible to use phage
as a therapeutic tool in the future. There are significant gaps in
our understanding of phage-host interactions which need to be
addressed before we can reach any conclusions on the usefulness
of phage as a biotherapeutic. By increasing our understanding of
phage-host interactions in the gut, it may be possible to pave the
way for therapeutic applications of phage in the human body.
However, the limited insights we have been granted to date of
phage-host interactions have also highlighted some significant
hurdles facing phage therapy. Early evidence that the virome
could play a role in the success of FMT (109, 145) suggests there
may be a future in using the virome to shape the microbiome
in disease. To date, the majority of phage intervention studies
are based on single phage-host pairs (or cocktails containing
limited numbers of phage) in vitro which have been shown
to be significantly different to phage-host dynamics in vivo
(112). For example, phage have been found to switch hosts
and interact directly with mammalian immune cells in vivo,
which has serious implications for the future of phage therapy
(134, 153). Additionally the phage-mediated transfer of host
virulence factors (23, 114, 168, 169) as well as direct pathogenesis
of phage capsids (142) suggests phage could be a potential risk
in therapeutic settings. These challenges are confounded with
regulatory issues (170) and additional gaps in our understanding
of the pharmacodynamics of phage in mammalian tissue. Having
the potential to directly interact with the immune system (86,
87, 136, 137) given their larger size relative to other biological
therapeutic agents makes phage a more complex therapeutic
agent than any that have preceded them. However, in light of the
increasing incidence of bacterial pathogens which are resistant
to antibiotics, and given the promising results of some existing
phage therapy trials (171–174), overcoming these challenges is
critically important. Similarly the gaps in our understanding
of how phage shape bacterial communities will need to be
addressed if phages are to have a role in avoiding future global
health issues.
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